MYELOPROLIFERATIVE NEOPLASMS (MPNS)
Clinical trials for MYELOPROLIFERATIVE NEOPLASMS (MPNS) explained in plain language.
Never miss a new study
Get alerted when new MYELOPROLIFERATIVE NEOPLASMS (MPNS) trials appear
Sign up with your email to follow new studies for MYELOPROLIFERATIVE NEOPLASMS (MPNS), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New pill tested for rare blood cancers
Disease control Recruiting nowThis is a first-in-human study to test the safety and find the right dose of an experimental oral drug called PRT12396 for people with certain rare blood cancers. It will enroll about 100 adults with high-risk polycythemia vera or myelofibrosis. The main goal is to see how well t…
Matched conditions: MYELOPROLIFERATIVE NEOPLASMS (MPNS)
Phase: PHASE1 • Sponsor: Prelude Therapeutics • Aim: Disease control
Last updated Apr 02, 2026 14:56 UTC
-
Massive 5,000-Person study launches to map the journey of rare blood cancers
Knowledge-focused Recruiting nowThis is a long-term observational study designed to better understand a group of rare, chronic blood cancers called myeloproliferative neoplasms (MPNs). It will follow 5,000 adults in the U.S. for 5-10 years, collecting health records and patient surveys to track symptoms, treatm…
Matched conditions: MYELOPROLIFERATIVE NEOPLASMS (MPNS)
Sponsor: MPN Research Foundation • Aim: Knowledge-focused
Last updated Apr 02, 2026 14:56 UTC